Lipicure Gold 40 Capsule is a combination pharmaceutical formulation containing Aspirin (75mg), Atorvastatin (40mg), and Clopidogrel (75mg), designed for the management of cardiovascular conditions. Aspirin, a well-known antiplatelet agent, inhibits cyclooxygenase enzymes, thereby reducing thromboxane A2 production and preventing platelet aggregation. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) levels, contributing to the stabilization of atherosclerotic plaques and reducing the risk of cardiovascular events. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet surfaces, further preventing platelet aggregation and thrombus formation. The synergistic action of these three agents makes Lipicure Gold 40 Capsule particularly useful in secondary prevention of myocardial infarction, stroke, and other atherothrombotic events in patients with established cardiovascular disease or high-risk profiles. It is essential that this medication be used under strict medical supervision, with regular monitoring of lipid profiles, bleeding parameters, and liver function tests. Caution is advised in patients with bleeding disorders, hepatic impairment, or those undergoing surgery. Lipicure Gold 40 Capsule offers a comprehensive approach to cardiovascular risk reduction by combining lipid-lowering and antiplatelet therapies in a single dosage form.